Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason R B Dyck

Showing results (101-110 of 236) with videos related to

Pageof 24
Sort By:
Diabetes|January 29, 2011
Hypoxia-induced intrauterine growth restriction increases the susceptibility of rats to high-fat diet-induced metabolic syndromeChristian F Rueda-Clausen, Vernon W Dolinsky, Jude S Morton, et al.
Journal of Molecular Medicine (Berlin, Germany)|March 10, 2011
Increased CD36 expression in middle-aged mice contributes to obesity-related cardiac hypertrophy in the absence of cardiac dysfunctionMiranda M Y Sung, Debby P Y Koonen, Carrie-Lynn M Soltys, et al.
Hypertension (Dallas, Tex. : 1979)|March 2, 2016
Perinatal Resveratrol Supplementation to Spontaneously Hypertensive Rat Dams Mitigates the Development of Hypertension in Adult OffspringAlison S Care, Miranda M Sung, Sareh Panahi, et al.
Science Translational Medicine|August 13, 2010
Fatty acid oxidation and malonyl-CoA decarboxylase in the vascular remodeling of pulmonary hypertensionGopinath Sutendra, Sebastien Bonnet, Gael Rochefort, et al.
Psychiatry Research|February 1, 2025
Potential benefits of ketone therapy as a novel immunometabolic treatment for schizophreniaKarin Huizer, Shubham Soni, Mya A Schmidt, et al.
American Journal of Physiology. Heart and Circulatory Physiology|July 2, 2017
Hearts lacking plasma membrane K<sub>ATP</sub> channels display changes in basal aerobic metabolic substrate preference and AMPK activityNermeen Youssef, Scott Campbell, Amy Barr, et al.
The Journal of Biological Chemistry|June 20, 2008
Resveratrol inhibits cardiac hypertrophy via AMP-activated protein kinase and AktAnita Y M Chan, Vernon W Dolinsky, Carrie-Lynn M Soltys, et al.
Journal of Molecular Medicine (Berlin, Germany)|November 15, 2014
Resveratrol prevents pathological but not physiological cardiac hypertrophyVernon W Dolinsky, Carrie-Lynn M Soltys, Kyle J Rogan, et al.
American Journal of Physiology. Heart and Circulatory Physiology|April 1, 2008
Metabolic actions of metformin in the heart can occur by AMPK-independent mechanismsRamesh Saeedi, Hannah L Parsons, Richard B Wambolt, et al.
Drug Development Research|July 12, 2024
Identification of aryl hydrocarbon receptor allosteric antagonists from clinically approved drugsFarag E S Mosa, Mohammed A Alqahtani, Mahmoud A El-Ghiaty, et al.
Pageof 24

Showing results (101-110 of 236) with videos related to

Sort By:
Pageof 24
Diabetes|January 29, 2011
Hypoxia-induced intrauterine growth restriction increases the susceptibility of rats to high-fat diet-induced metabolic syndromeChristian F Rueda-Clausen, Vernon W Dolinsky, Jude S Morton, et al.
Journal of Molecular Medicine (Berlin, Germany)|March 10, 2011
Increased CD36 expression in middle-aged mice contributes to obesity-related cardiac hypertrophy in the absence of cardiac dysfunctionMiranda M Y Sung, Debby P Y Koonen, Carrie-Lynn M Soltys, et al.
Hypertension (Dallas, Tex. : 1979)|March 2, 2016
Perinatal Resveratrol Supplementation to Spontaneously Hypertensive Rat Dams Mitigates the Development of Hypertension in Adult OffspringAlison S Care, Miranda M Sung, Sareh Panahi, et al.
Science Translational Medicine|August 13, 2010
Fatty acid oxidation and malonyl-CoA decarboxylase in the vascular remodeling of pulmonary hypertensionGopinath Sutendra, Sebastien Bonnet, Gael Rochefort, et al.
Psychiatry Research|February 1, 2025
Potential benefits of ketone therapy as a novel immunometabolic treatment for schizophreniaKarin Huizer, Shubham Soni, Mya A Schmidt, et al.
American Journal of Physiology. Heart and Circulatory Physiology|July 2, 2017
Hearts lacking plasma membrane K<sub>ATP</sub> channels display changes in basal aerobic metabolic substrate preference and AMPK activityNermeen Youssef, Scott Campbell, Amy Barr, et al.
The Journal of Biological Chemistry|June 20, 2008
Resveratrol inhibits cardiac hypertrophy via AMP-activated protein kinase and AktAnita Y M Chan, Vernon W Dolinsky, Carrie-Lynn M Soltys, et al.
Journal of Molecular Medicine (Berlin, Germany)|November 15, 2014
Resveratrol prevents pathological but not physiological cardiac hypertrophyVernon W Dolinsky, Carrie-Lynn M Soltys, Kyle J Rogan, et al.
American Journal of Physiology. Heart and Circulatory Physiology|April 1, 2008
Metabolic actions of metformin in the heart can occur by AMPK-independent mechanismsRamesh Saeedi, Hannah L Parsons, Richard B Wambolt, et al.
Drug Development Research|July 12, 2024
Identification of aryl hydrocarbon receptor allosteric antagonists from clinically approved drugsFarag E S Mosa, Mohammed A Alqahtani, Mahmoud A El-Ghiaty, et al.
Pageof 24